Catabasis Pharmaceuticals to Present at 2017 Wedbush PacGrow Healthcare Conference
August 09 2017 - 8:00AM
Business Wire
Catabasis Pharmaceuticals, Inc. (NASDAQ:CATB), a clinical-stage
biopharmaceutical company, today announced that Jill C. Milne,
Ph.D., Chief Executive Officer, will present a corporate and
pipeline overview at the 2017 Wedbush PacGrow Healthcare Conference
on Wednesday, August 16, 2017 at 10:20am ET at the Le Parker
Meridien Hotel in New York, NY.
A webcast of the presentation will be available in the Investors
section of the Company’s website, www.catabasis.com, and will be
archived for 30 days following the presentation.
About CatabasisAt Catabasis Pharmaceuticals, our mission
is to bring hope and life-changing therapies to patients and their
families. Our SMART (Safely Metabolized And Rationally Targeted)
Linker drug discovery platform enables us to engineer molecules
that simultaneously modulate multiple targets in a disease. We are
applying our SMART LinkerSM platform to build an internal pipeline
of product candidates for rare diseases and plan to pursue
partnerships to develop additional product candidates. For more
information on the Company's drug discovery platform and pipeline
of drug candidates, please visit www.catabasis.com.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20170809005202/en/
Investor and Media ContactCatabasis
Pharmaceuticals, Inc.Andrea Matthews,
617-349-1971amatthews@catabasis.com
Catabasis Pharmaceuticals (NASDAQ:CATB)
Historical Stock Chart
From Mar 2024 to Apr 2024
Catabasis Pharmaceuticals (NASDAQ:CATB)
Historical Stock Chart
From Apr 2023 to Apr 2024